ImmunOs Therapeutics

Acquisition, funding and merger involving ImmunOs Therapeutics.

• ImmunOs Therapeutics has just announced a $74 Million fundraising (posted on June 8 2022).

View the org chart displaying its 17 main executives

Most searched biographies at ImmunOs Therapeutics

• Sean Smith, Chief Executive Officer and Director
• Shelley Chu, Director
• Markus Hosang, Director

Popular executive movements at ImmunOs Therapeutics

• Constanze Guenther has joined the company as Senior Vice President, Chemistry, Manufacturing, Controls and Technical Development  (posted on September 19 2023).

Create your alert
to follow the executive moves at ImmunOs Therapeutics.

ImmunOs Therapeutics has 2,282 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by ImmunOs Therapeutics

• News & Media - Immunostherapy

Social media about ImmunOs Therapeutics

• ImmunOs Therapeutics on Wikipedia, Google News & Yahoo Finance
• ImmunOs Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Sean Smith

Call ImmunOs Therapeutics at +49 408...

View the org chart

Register to receive your alert

Report an error